Phase 2 Motion sickness Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Motion sicknessMotion Sickness, SpaceSea Sickness
Repurposed Therapeutics, Inc.30 enrolled1 locationNCT05886660
Recruiting
Phase 2
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Motion Sickness, SpaceMotion SimulationParabolic Flight
Repurposed Therapeutics, Inc.80 enrolled1 locationNCT05852730
Completed
Phase 2
The effects of cannabidiol (CBD) on psychosocial stress, situational anxiety and nausea experienced in a virtual reality environment
Psychosocial stressMotion sicknessCybersickness
University of Sydney74 enrolled1 locationACTRN12623000872639